|
Jill joined Alquest in 2004. A highly accomplished medical device executive, she oversees Alquest’s rapidly growing presence in the San Francisco Bay Area. Jill joined Alquest from Boston Scientific Corporation, where she had served as Director of Enteryx Clinical Research. Previously Jill had been Vice President, Clinical and Regulatory Affairs for Enteric Medical Technologies; Senior Manager of Clinical and Regulatory Affairs for Metra Biosystems; Senior Development Scientist for Dade-Behring Diagnostics; and Raw Material Chemist for Monoclonal Antibodies, Inc. During her career, Jill established regulatory and clinical strategy and requirements definition for gastroenterology, ultrasound imaging and IVD products. She has planned and managed FDA pre-submission and panel meetings; and developed and obtained clearance/approval for numerous submissions including premarket notifications, IDE applications, PMA applications, IDE supplements and annual reports, and CE Mark technical files. Jill earned a B.S. in Biological Sciences from Florida State University and a M.S. in Pharmaceutical Chemistry from the University of Florida. | 